<qa>  What is the name of the LABEL STUDY INVESTIGATING SAFEOPEN LABEL STUDY INVESTIGATING SAFETY AND EFFICACY OF NPL2009 50 MG - 150 MG ON PREPULSE INHIBITION TESTS AND CONTINUOUS PERFORMANCE TASKS, ADULTS WITH FRAGILE X SYNDROME: 